GL1X · GenesisL1 explorer

Research workbench

Crystal structure of GLU335GLN mutant of clostridium botulinum neurotoxin E catalytic domain

Analyse Crystal structure of GLU335GLN mutant of clostridium botulinum neurotoxin E… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1ZL5
Type
protein
Length
787 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin type E
EC
3.4.24.69
UniProt
Q00496
Ligands
CL
Pockets
6 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 34% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin type E (EC 3.4.24.69)protein40034% helix, 17% strandQ00496
BBotulinum neurotoxin type E (EC 3.4.24.69)protein38735% helix, 18% strandQ00496

Ligands and binding sites

  • CL · Chloride ion · ion · 8 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110740.820.83111empty
21640.530.7932empty
31930.520.7836CL
4780.360.7625empty
5650.330.7623empty

Interfaces

1 interface between chains.

  • A–B · 1271 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 1ZL5 · Crystal structure of Glu335Gln mutant of Clostridium botulinum neurotoxin E catalytic… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q00496 · AlphaFold monomer V2.0 prediction for botulinum neurotoxin type E (Q00496) · a predicted model of the same protein · chain B against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.